Using routine data to inform UK NHS of the costs and budgets impact on managing Primary Liver Cancer

Organisation/institution: Swansea Centre of Health Economics (SCHE) at Swansea University and the Hepatocellular Carcinoma (HCC)/National Cancer Registration and Analysis Service (NCRAS) Partnership Steering Group.

Key Contact: Katherine Cullen, SCHE, Swansea University, katherine.cullen@swansea.ac.uk

What was the question that we could help with?

An emerging theme has been the use and application of routine data to inform health economic analysis, with a number of projects in progress working with SAIL, CPRD and NHS datasets. Health and Care Economics Cymru researchers have recently completed a project with the Hepatocellular Carcinoma (HCC)/National Cancer Registration and Analysis Service (NCRAS) Partnership Steering Group. This is a UK wide group of HCC clinical specialists, Public Health England and Wales and researchers working in partnership on several linked projects to understand the current management and outcomes of HCC in the UK

What did we do?

We undertook a literature review and budget impact analysis of HCC treatment pathways in NHS England. The health economics team designed a novel data analysis plan for the budget impact analysis, including the use of decision analytic modelling to estimate the costs of HCC across different treatment pathways, stratified by treatment intent, underlying liver disease status and patient characteristics, as part of applying real-world analysis to routine clinical practice.

People working collaboratively on a laptop

What is the expected impact?

A full report on the budget impact analysis has been submitted to the partnership steering group, which will form the basis of a paper. Abstracts are also being prepared for submission at conferences such as BSG.

We expect that the delivery of high-quality evidence will lead to the commissioning of services for people with HCC, support NHS budget decisions and value-based healthcare.